Stockreport

Immunomodulators Global Business Analysis Report 2024-2030: Growing Focus on Combination Therapies Enhances Market Opportunities, Increased Focus on Developing Targeted Therapies [Yahoo! F...

Abbott Laboratories  (ABT) 
Last abbott laboratories earnings: 4/16 07:30 am Check Earnings Report
US:NYSE Investor Relations: abbott.com/investors.html
PDF The global market for Immunomodulators was estimated at US$248.0 Million in 2023 and is projected to reach US$364.7 Million by 2030, growing at a CAGR of 5.7% from 2023 [Read more]